Insulin Producing Stem Cell Transplantation Clinical Trial in Type 1 Diabetes

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

May 1, 2026

Study Completion Date

September 1, 2026

Conditions
Stem CellsType 1 Diabetes
Interventions
BIOLOGICAL

Insulin producing stem cells infusion

"1. Liposuction of the anterior abdominal subcutaneous fat layer of participant~2. Characterization and Identification of mesenchymal stem cells~3. Differentiation of mesenchymal stem cells into insulin producing stem cells~4. In vitro detection of Insulin and c-peptide in differentiated MSC (Confirmatory tests for the insulin producing cells)~5. In vitro Insulin and c-peptide release detection in differentiated MSC in response to increasing glucose concentrations Differentiated MSCs injection in human subjects~6. Followup"

Trial Locations (1)

Unknown

RECRUITING

Children Hospital Eldemerdash, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER